Longitudinal loss of skeletal muscle mass during systemic cancer treatment as prognostic indicator for overall survival: A systematic review and meta-analysis
1 outlet · first reported by Clinical Nutrition 3d ago
Coverage, in order
-
3d agoLongitudinal loss of skeletal muscle mass during systemic cancer treatment as prognostic indicator for overall survival: A systematic review and meta-analysis
Loss of skeletal muscle mass (SMM) during systemic anticancer treatment is common, but its prognostic significance across cancer types and treatment modalities has not been systematically quantified. This study aimed to review the literature and perform a meta-analysis exploring the association…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.